Aguilar Laura K.'s Form 4 filing
Candel Therapeutics, Inc. (CADL) · filed Oct 3, 2024
- Accession no.
- 0001873919-24-000001
- Filed
- Oct 3, 2024, 6:19 PM ET
- Trade date
- Oct 1-3, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $242.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Aguilar Laura K.CIK 0001873915 | 10% Owner |
| Aguilar-Cordova EstuardoCIK 0001873919 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2024 | CADL | SSaleAcquired | +6,214 | $7.01 | +$43,554.55 | 988,661 | Direct | |
| Oct 2, 2024 | CADL | SSaleDisposed | −26,988 | $6.92 | −$186,756.96 | 961,673 | Direct | |
| Oct 3, 2024 | CADL | SSaleDisposed | −1,800 | $6.85 | −$12,330 | 959,873 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.